 HAIKOU, China, Aug. 13, 2021 PRNewswire -- China Pharma Holdings, Inc. NYSE American: CPHI China Pharma, the Company or We, an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended June 30, 2021. Revenue decreased by 35.9 to 2.4 million for the three months ended June 30, 2021, as compared to 3.8 million for the three months ended June 30, 2020. 